Get latest articles and stories on India at LatestLY. The government on Wednesday formed a four-member panel of experts to examine the details and adverse event reports received from the WHO on the deaths of 66 children in The Gambia being linked potentially to the four made-in-India cough syrups, official sources here said. India News | Govt Forms Panel to Study WHO Report on Deaths of 66 Gambian Children Linked to 4 Indian Syrups.
A four-member committee of technical experts consists of Dr. Y. K Gupta, Dr Pragya D. Yadav, Dr. Arti Bahl and A. K. Pradhan to study the report of the World Health Organization s report on the death of several children in Gambia.
The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceuticals, and asked it to explain within a week many contraventions found during a recent inspection, or face suspension or cancellation of license.
The World Health Organisation (WHO), which recently issued a medical health alert against cough syrups manufactured by Indian firm Maiden Pharmaceuticals following the death of 66 children in Gambia, on October 29 informed the Drug Controller General of India (DGCI) that it collected 23 samples of medicines under reference for further testing and four samples were found to be contaminated with diethylene glycol/ ethylene glycol an ingredient which may have contributed to the death of the children.